SINGAPORE - Singapore O&G (SOG) capped off 2015 with solid earnings growth and a bright outlook, as the women's clinic and healthcare operator maintained its strong momentum since the stellar Catalist debut in June.
Net profit for the full year rose 25.7 per cent year-on-year to $5.34 million, on the back of a 21.1 per cent increase in revenue to $16.41 million, SOG announced on Feb 3.
Earnings per share shot up 25.6 per cent year-on-year to 2.45 cents, and net asset value rose 62 per cent to 11.01 cents per share.
"Our main growth drivers were the obstetrics and cancer specialist segments. In 2015, we delivered 1,633 babies, up from 1,462 in 2014," chief executive Dr Ng Koon Keng told the Straits Times.
Despite the growth, SOG only has around 6.7 per cent share in the private delivery market, "so I think we still have plenty of room for growth in Singapore," Dr Ng added.
Upside for the cancer specialist segment is also expected, as SOG has recruited a new breast surgeon Dr Lim Siew Kuan, who will join the team in May.
A final dividend of 1.15 cents a share was declared. SOG already paid out a 0.88 cents interim dividend in Sept 3, pushing the full year distribution to 87.2 per cent of net profit - just below the 90 per cent maximum set by its dividend policy.
"With all our pieces for growth in place, we hope to maintain a good level of dividend payout in 2016," Dr Ng said.
SOG had a strong debut on the Catalist board last June, and its share price has gained some 185 per cent. On Wednesday the shares closed 1.5 cents or 2.08 per cent down at 70.5 cents.
The company's success as a company and a stock is part of the bullish story around the healthcare sector, which has remained resilient despite the strong market and economic headwinds last year.
UG Healthcare, an examination glove manufacturer, also reported earnings growth for the six months to Dec 31.
Its Revenue for the period grew 20.1 per cent year-on-year to $30.14 million, leading to a 34 per cent increase in net profit to$3.23 million.
No dividend was declared for the period.
UG Healthcare's share closed 0.5 cents or 1.54 per cent down at 32 per cent on Wednesday, ahead of the results announcement.
UG Healthcare will continue ramping up its production capacity, with a target of another 400 to 500 million gloves annually by June 2017, executive director Lee Jun Yih said when announcing the results.